Poland· PL-100424330
Ervebo
A ebola-impfstoffe product containing szczepionka przeciw chorobie wywołanej przez wirus ebola-zaire (rvsv∆g-zebov-gp, żywa), registered in Poland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ebola-impfstoffe is registered in 9 of 19 countries.
Countries holding a registration under ATC J07BX02 (ebola-impfstoffe), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Ebola-impfstoffe · ATC J07BX02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka przeciw chorobie wywołanej przez wirus Ebola-Zaire (rVSV∆G-ZEBOV-GP, żywa)
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Poland (PL)
- ATC code
- J07BX02
- ATC class
- Ebola-Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX02
Ebola-impfstoffe, as other registers publish it.
- FinlandErveboMerck Sharp & Dohme B.V.
- BelgiumErveboMerck Sharp & Dohme
- DenmarkErveboMerck Sharp & Dohme B.V.
- IcelandErveboMerck Sharp & Dohme B.V.*
- CzechiaERVEBOMerck Sharp & Dohme B.V., Haarlem
- IrelandErvebo solution for injectionMerck Sharp & Dohme BV,
- SwitzerlandErvebo, InjektionslösungMSD Merck Sharp & Dohme AG
- NetherlandsErvebo, oplossing voor injectieMerck Sharp & Dohme B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9564d484-be6e-4acb-b14e-487e91af8b60 GET /v1/drugs/9564d484-be6e-4acb-b14e-487e91af8b60?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "≥ 72 miliony pfu/ml",
"packaging": "Rp ¦ EU/1/19/1392/001 ¦ 135068\n10 fiol.",
"substance": "Rekombinowany wirus pęcherzykowego zapalenia jamy ustnej (rVSV) szczep Indiana z delecją genu kodującego glikoproteinę otoczki (G) wirusa VSV, który zastąpiono sekwencją kodującą glikoproteinę powierzchniową (GP) 1 ml",
"common_name": "Szczepionka przeciw chorobie wywołanej przez wirus Ebola-Zaire (rVSV∆G-ZEBOV-GP, żywa)",
"pl_product_id": "100424330",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about ebola-impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.